Astrazeneca ensures 100 percent protection against severe corona courses



[ad_1]

Astrazeneca can be approved by the therapeutic products authority Swissmedic at any time. The company now publishes the results of the first analysis of the final phase of clinical trials.

The vaccine “protects 100 percent against serious illness, hospitalization, and death,” writes Astrazeneca. More than 22 days after the first dose.

[ad_2]